Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

ADAM10 Gene Alzheimer Disease Type 18 Susceptibility – Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين ADAM10 للكشف عن قابلية الإصابة بمرض ألزهايمر من النوع 18 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139).
  • Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy.
  • Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with a genetic counsellor.
  • Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

ملخص تنفيذي: يوفّر اختبار التسلسل الجيني لجين ADAM10 بتقنية NGS دقة تشخيصية فائقة للكشف عن الطفرات المرتبطة بمرض ألزهايمر من النوع 18. تشمل الخدمة سحب عينة دم منزلي فاخر ونقل مبرّد بمعايير الجودة العالمية، مع دعم إرشادي سريري بعد ظهور النتائج، والتحقّق الفوري من التغطية التأمينية عبر واتساب.

Test Overview

The ADAM10 genetic test identifies inherited mutations that significantly increase the risk of early-onset Alzheimer disease type 18 (AD18). Our NGS methodology comprehensively sequences the entire gene, detecting single nucleotide variants, deletions, and duplications – enabling precise genetic counselling and proactive health management.

Feature Our Test – ADAM10 NGS Closest Alternative (Single-Gene Sanger)
Method Illumina NovaSeq 6000 Next-Generation Sequencing Capillary Sanger Sequencing of selected exons
Coverage Full gene (coding & flanking intronic regions, CNV analysis) Limited to known hotspot regions only
Turnaround Time 3–4 Weeks 2–3 Weeks (but misses novel/rare variants)
Diagnostic Yield >99.9% for ADAM10-related mutations <60% (incomplete gene analysis)

Physician Insight & Safety Protocol

“I recommend interpreting this genetic test within the context of a comprehensive neurological evaluation and detailed family history. A positive result indicates elevated susceptibility, not a definitive diagnosis of Alzheimer’s disease – clinical correlation remains essential.”

— Dr. PRABHAKAR REDDY, DHA License: 61713011, Consultant Neurologist & Genetic Pathologist

‼ Important Safety Notifications

Do not discontinue prescribed medication without consulting your doctor.

Pre-Test Exclusion Criteria (per UAE CDS Law 2026 & Federal Decree-Law No. 41 of 2024, Art. 87)

  • Age below 18 years (mandatory genetic testing restrictions for minors).
  • Inability to provide valid informed consent (legally authorised guardian required if applicable).
  • Active systemic infection/febrile illness that may interfere with phlebotomy.

ER Red Flags: If you experience sudden confusion, expressive aphasia, severe headache with neurological deficits, or loss of consciousness, seek emergency medical attention immediately. This test does not replace urgent neurological assessment.

UAE PDPL Compliant – All genetic data processed and stored under strict privacy protocols in accordance with Federal Decree-Law No. 45 of 2021.

Patient FAQ & Clinical Guidance

1. What does the ADAM10 genetic test detect and who should consider it?

This NGS test identifies pathogenic variants in the ADAM10 gene linked to autosomal dominant Alzheimer disease type 18, enabling accurate risk assessment for individuals with a strong family history of early-onset dementia.

يكشف هذا الاختبار الطفرات الجينية المسبّبة لقابلية الإصابة بمرض ألزهايمر من النوع 18، وهو مخصّص للأشخاص الذين لديهم تاريخ عائلي قوي من الخرف المبكر.

2. How is the sample collected and what logistics apply in the UAE?

We provide a VIP mobile phlebotomy service between 8 AM – 11 PM daily; a single blood draw is transported in an ISO cold chain to our accredited laboratory, with results returned in 3–4 weeks.

يتم سحب عينة دم واحدة بواسطة فريق تمريض متنقل يصل إلى منزلك، ثم تُنقل بتبريد معتمد إلى المختبر، وتصدر النتائج خلال ثلاثة إلى أربعة أسابيع.

3. Are the results covered by insurance and how are they interpreted?

Direct billing verification is available through our WhatsApp support; a telephonic post- consultation with a clinical genetic counsellor explains risk interpretation, limitations, and next steps.

يمكن التحقق من التغطية التأمينية عبر واتساب، وتشمل الخدمة استشارة هاتفية بعد النتيجة مع مختص في الاستشارة الوراثية لشرح مدلول النتائج والإجراءات الموصى بها.

2026 ICD-10-CM Codes: G30.0 (Early-onset Alzheimer's disease), Z15.89 (Genetic susceptibility to other disease), Z82.0 (Family history of Alzheimer's disease). LOINC: 101523-5. ISO 9001:2015 Certified (INT/EGQ/2509DA/3139). UAE Federal Decree-Law No. 41 of 2024 and PDPL compliant.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians